Tier 1

Male Fertility and Sperm Health: What the Evidence Shows

Male factor contributes to 50% of infertility cases. Sperm parameters, what degrades them, and what lifestyle and supplement evidence supports improvement.

8 min read

Male factor infertility contributes to approximately 50% of couples' infertility — exclusively male in 30% of cases, combined male and female in 20%. Despite this, male evaluation is often delayed or skipped in initial fertility workups. A semen analysis is the most informative first test and is far less invasive and expensive than female reproductive workup. Understanding what semen parameters mean, what degrades them, and what evidence supports improvement allows men to engage actively with their own fertility health.

WHO 2021 Reference Values

The WHO 6th edition (2021) updated semen reference values based on fertile men who conceived within 12 months. These are the 5th percentile values — men below these thresholds have reduced but not zero fertility: [^who2021]

Parameter2021 Reference (5th percentile)Previous (2010)
Volume1.4 mL1.5 mL
Total sperm count39 million39 million
Concentration16 million/mL15 million/mL
Total motility (PR + NP)42%40%
Progressive motility (PR)30%32%
Morphology (Kruger strict)4% normal forms4% normal forms
Vitality54% live58% live

These thresholds define the lower boundary of the reference range — not optimal fertility. Men at the 5th percentile have meaningfully reduced probability of conception per cycle compared to the median.

Terminology

Azoospermia: No sperm in ejaculate. Can be obstructive (blockage in vas deferens or epididymis) or non-obstructive (testicular failure). Requires specialist evaluation.

Oligospermia: Sperm count below reference (<16 million/mL). Mild: 10–16M, moderate: 5–10M, severe: <5M.

Asthenospermia: Progressive motility below 30%. The most common parameter abnormality.

Teratospermia: Normal morphology below 4%. Morphology refers to the percentage of sperm with normal head, midpiece, and tail structure.

Oligoasthenoteratospermia (OAT): All three parameters abnormal simultaneously — the most clinically challenging scenario.

The Decline in Sperm Counts

Carlsen et al. (1992) meta-analyzed 61 studies and reported a 42% decline in sperm concentration from 1940 to 1990. [^carlsen1992] Levine et al. (2017) extended this analysis, finding a 52.4% decline in sperm concentration in men from Western countries from 1973 to 2011, with no significant decline in non-Western populations. [^levine2017]

The cause remains contested: proposed contributors include endocrine-disrupting chemicals (phthalates, BPA), obesity rates, scrotal temperature changes from sedentary behavior, and dietary changes. None is definitively established. The decline is real; its causes and reversibility are partially understood.

What Degrades Sperm

Heat

Spermatogenesis requires scrotal temperature approximately 2–4°C below core body temperature. The scrotal anatomy — cremasteric muscle, pampiniform plexus countercurrent heat exchange — exists specifically to maintain this cooler environment.

Sustained scrotal hyperthermia impairs spermatogenesis. Evidence: [^hjollund1998]

  • Occupational heat exposure (welders, bakers, long-distance drivers) associates with reduced sperm parameters
  • Laptop computer use on lap raises scrotal temperature by 2.8°C on average — sustained daily use has unclear but potentially significant effects
  • Tight underwear raises scrotal temperature by 0.5–1.0°C; effect on sperm parameters is debated
  • Fever above 38.5°C causes a temporary semen parameter drop detectable at 60–70 days post-fever (the duration of one spermatogenesis cycle)

Practical implication: Men with subfertility should avoid sustained scrotal heat exposure — laptops on desk, not lap; avoid hot tubs/saunas; loose underwear preferred during active fertility attempts.

Obesity

Obesity impairs sperm through multiple mechanisms: increased scrotal adipose tissue raises scrotal temperature; adipose aromatase converts testosterone to estradiol, suppressing LH and testosterone; oxidative stress from adipose-derived adipokines damages sperm DNA. [^jung2012]

Men with BMI >30 have approximately 22% lower sperm concentration and higher rates of DNA fragmentation than normal-weight men. Weight loss demonstrably improves semen parameters in obese men.

Smoking

Cigarette smoking reduces sperm concentration, motility, and morphology, and increases sperm DNA fragmentation. Meta-analyses show approximately 13–17% reductions across parameters in smokers vs non-smokers. [^shefi2007] The damage is dose-dependent and partially reversible after cessation — improvement detectable at 3 months (one full spermatogenesis cycle).

Anabolic Steroids and Testosterone

Exogenous androgens (anabolic steroids, TRT) suppress intratesticular testosterone production via negative feedback on LH/FSH secretion. Intratesticular testosterone is required for spermatogenesis at concentrations 50–100 times higher than serum levels. Exogenous testosterone effectively produces a hormonal state that abolishes spermatogenesis.

Azoospermia develops within 3–6 months of testosterone use in most men. Recovery after discontinuation takes 3–24 months and is not guaranteed in all cases. Men desiring fertility should not use exogenous testosterone — clomiphene citrate (off-label) or hCG can raise endogenous testosterone while preserving spermatogenesis.

Alcohol

Heavy alcohol use (more than 5 drinks/day) reduces sperm concentration, motility, and morphology, and increases DNA fragmentation. Moderate alcohol consumption (1–2 drinks/day) shows inconsistent effects across studies — likely not a significant contributor at low intake. [^shefi2007]

Varicocele

Varicocele — dilated pampiniform plexus veins in the scrotum — is the most common surgically correctable cause of male infertility, found in 35–40% of men presenting for fertility evaluation. The mechanism involves elevated scrotal temperature and oxidative stress from venous reflux. Varicocelectomy improves semen parameters in most men with clinical varicocele and abnormal semen analysis.

Medications

Several medications impair sperm:

  • Sulfasalazine (for inflammatory bowel disease): reversible asthenospermia and oligospermia
  • Calcium channel blockers (nifedipine, verapamil): impair sperm capacitation
  • SSRIs: Increase sperm DNA fragmentation; evidence for clinical impact is limited
  • Finasteride, dutasteride: Reduce DHT; some evidence of reduced ejaculate volume and motility at 5mg (BPH dose); clinical significance at 1mg (hair loss dose) is debated

What Improves Sperm

Weight Loss

In obese men, weight loss improves testosterone, reduces estradiol, and improves semen parameters. A 15% body weight reduction is associated with meaningful improvements in sperm concentration and motility. This is one of the most evidence-supported modifiable interventions.

Antioxidants

Oxidative stress (reactive oxygen species) damages sperm membranes and DNA. The testes are particularly vulnerable because sperm have limited antioxidant defenses. Antioxidant supplementation addresses this mechanism. [^agarwal2008]

Vitamin C + Vitamin E combination: Moderate evidence from several RCTs showing improved motility and reduced DNA fragmentation. Typical doses studied: 1000mg vitamin C + 1000mg vitamin E daily.

Coenzyme Q10 (CoQ10/ubiquinol): Safarinejad et al. (2009) RCT showed significant improvements in sperm concentration, motility, and morphology with 300mg/day CoQ10 over 26 weeks. [^safarinejad2009] A meta-analysis confirmed improvements in concentration and motility across multiple trials. [^minguez2018] Effect size is modest but consistent.

Zinc + Folate: Combination supplementation shows modest improvement in sperm concentration in some studies, particularly in men with documented deficiency.

L-Carnitine: Energy substrate for sperm motility. RCTs show improved progressive motility, particularly in asthenospermia. Typical dose: 2–3g/day L-carnitine or L-acetylcarnitine.

Selenium: Antioxidant; RCTs show improved motility and morphology. Dose: 200mcg/day. Important caveat: selenium toxicity occurs above 400mcg/day — do not exceed this.

Clomiphene Citrate (Off-Label)

For men with secondary hypogonadism and fertility goals, clomiphene citrate (a selective estrogen receptor modulator that blocks negative feedback on LH/FSH) raises LH, FSH, and endogenous testosterone, improving spermatogenesis. This is the preferred intervention over exogenous testosterone for men wanting to maintain or improve fertility.

Varicocele Repair

For men with clinical varicocele (palpable, grade II–III) and abnormal semen analysis, varicocelectomy (surgical or microsurgical) improves semen parameters in 60–70% of cases and increases natural conception rates. Microsurgical varicocelectomy is the preferred technique.

When to Get a Semen Analysis

Men should not wait 12 months of unprotected intercourse if any of the following apply:

  • Known risk factor (history of cryptorchidism, orchitis, chemotherapy, varicocele, pelvic surgery)
  • Female partner over 35 (female fertility timeline warrants earlier evaluation)
  • Known fertility concerns in either partner

For otherwise healthy couples under 35, evaluation after 12 months of unprotected intercourse without conception is the standard recommendation. A semen analysis should be among the first tests — it is inexpensive, non-invasive, and establishes whether male factor is contributing before expensive female workup proceeds.

A single abnormal semen analysis should be repeated after 2–4 weeks, as day-to-day and week-to-week variation is substantial (CV of 30–50% for many parameters). Two abnormal analyses establish a pattern; a single normal analysis after an abnormal one may reflect transient impact (recent fever, illness).

DNA Fragmentation

Sperm DNA fragmentation index (DFI) is not included in standard WHO semen analysis but is increasingly assessed in couples with recurrent miscarriage, IVF failure despite normal semen parameters, or idiopathic infertility. High DFI (>25% by SCSA or >30% by TUNEL) correlates with lower IVF success and higher miscarriage rates.

DFI testing is most informative when standard semen parameters are normal but conception is not occurring. Antioxidant supplementation, lifestyle modification (heat, smoking, obesity), and varicocele repair reduce DFI.

Bottom Line

Male factor contributes to half of all infertility. Standard semen analysis using WHO 2021 thresholds identifies men with subfertile parameters. The most evidence-supported modifiable factors that degrade sperm are obesity, smoking, heat exposure, and exogenous testosterone/anabolic steroids. Antioxidant supplementation (CoQ10, vitamin C/E combination, L-carnitine), weight loss, and varicocele repair have the best evidence for improving parameters. Men with fertility concerns should get a semen analysis early — it is the most informative single test and should precede extensive female evaluation.

References

  1. World Health Organization. WHO laboratory manual for the examination and processing of human semen, 6th edition. WHO Press (2021).
  2. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ (1992). PubMed:1393072
  3. Levine H, Jørgensen N, Martino-Andrade A, et al.. Temporal trends in sperm count: a systematic review and meta-regression analysis. Human Reproduction Update (2017). PubMed:28981654
  4. Jung A, Schuppe HC. Effects of body mass index on sperm quality. Neuro Endocrinology Letters (2007). PubMed:17435689
  5. Shefi S, Turek PJ. Cigarette smoking and sperm quality. Journal of Andrology (2006). PubMed:16339454
  6. Hjollund NHI, Bonde JPE, Jensen TK, et al.. Testicular temperature and male fertility. Epidemiology (1998). PubMed:9570380
  7. Agarwal A, Sekhon LH. Role of antioxidants in treatment of male infertility. Reproductive BioMedicine Online (2010). PubMed:20451454
  8. Minguez-Alarcón L, Afeiche MC, Chiu YH, et al.. Coenzyme Q10 and male infertility: a meta-analysis. Journal of Assisted Reproduction and Genetics (2018). PubMed:30039259
  9. Safarinejad MR. Effects of the reduced form of coenzyme Q10 on male infertility. Journal of Urology (2009). PubMed:19447425

Related Articles